Skip to Main Content

Paper Details

Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema.
J Plast Reconstr Aesthet Surg
10
2022
Author NameAffiliation
Kari AlitaloWihuri Research Institute and Translational Cancer Medicine Program, University of Helsinki
  • 1 - 1

Datasets

Release 1.2